Skip to main content
Dupilumab significantly improves markers of AD severity in pediatric patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dupilumab significantly improves markers of AD severity in pediatric patients
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Pain Management
0
0.77
Child
0
0.98
Biomarker
0
0.66
Pediatric Dermatology
0
0.51
Biologic Therapy
0
0.41
Patient Safety
0
0.28
Adverse Effects
0
0.18
Cornea and External Disease
0
0.16
Atopic Dermatitis
0
0.99
Chemokines
0
0.12
Conjunctivitis
0
0.12
Eczema
0
0.12
Interleukin-2
0
0.1
Headache
0
0.08
Healthcare and Medical Technology
0
0.08
Adolescent Medicine
0
0.06
Allergy
0
0.06
Blood
0
0.06
Clinical Research
0
0.06
Europe
0
0.06
Hospital
0
0.06
Immunology
0
0.06
Interleukin
0
0.06
Monoclonal Antibody
0
0.06
Pain
0
0.06
Pruritus
0
0.06
Quality of Life
0
0.06
Receptors
0
0.06
Severity Index
0
0.06
Targeted Cancer Therapy
0
0.06
Texas
0
0.06
Thymus
0
0.06
Specialty
Lead
score
Pediatrics
1
1
Dermatology
0
0.9
Family Medicine/Primary Care
0
0.8
Edit Tags